Posted on June 26, 2025 14:02 PM
I am excited to share that Distributor Connect & Consulting Pte
Ltd (DCCL) has successfully completed a Commercial Due
Diligence (CDD) project for a leading Europe-based MNC with a
turnover of approx. USD 12.5 billion on a potential acquisition
target.
This marks a significant milestone for DCCL, as we expand our expertise into
M&A due diligence—a natural extension of our work in market
entry strategy and distributor network optimization. With M&A
activity surging in the Asia-Pacific healthcare sector, driven by high
growth in the healthcare industry and increasing Private Equity (PE)
investments, we see immense potential in this new advisory stream.
Our CDD process involved a comprehensive assessment
of the target company, including:
✅ Country macroeconomic and regulatory
landscape
✅
Business model and operating structure
✅
Revenue analysis & forecasts
✅
Portfolio of services and client contracts
✅
Client concentration & segmentation
✅
Business development practices & processes
✅
Competition
✅
Synergies in overlapping services
✅
Opportunities in complementary services
✅
Future growth potential
✅
Key risks
We leveraged a mix of in-depth desk research and face-to-face
meetings with the target company's senior management to gain valuable
insights.
Earlier, for the same client, we had authored a market entry
strategy report, which included a shortlist of potential
partners and acquisition targets. The progression from market
entry advisory to due diligence highlights DCCL’s ability to support
clients across the entire expansion lifecycle—from identifying
opportunities to validating investment decisions.
As we embark on our next project with a PE-backed healthcare company,
helping them identify acquisition targets across Asia, I look
forward to deepening DCCL’s impact in this space.
Would love to hear from peers and industry leaders on how M&A
dynamics are evolving in APAC healthcare. Let’s
connect!